Merck to manufacture Janssen s COVID-19 vaccine europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
In a rare deal between competitors, pharmaceutical major Merck, known as MSD outside the US and Canada, has inked a deal to support efforts to expand manufacturing capacity and supply of Johnson and Johnson s Covid-19 vaccine, American .
President Biden announced that pharmaceutical giant Merck will help make Johnson & Johnson’s single-shot coronavirus vaccine an unusual pact between rivals.
Merck known as MSD outside the United States and Canada, announced today it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority a division of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services … Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2/COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), will provide Merck with funding of up to $268.8 million to adapt and make available a number of existing manufacturing
Skip to main content
Merck will help make Johnson & Johnson coronavirus vaccine as rivals team up to help Biden accelerate shots
Laurie McGinley and Christopher Rowland, The Washington Post
March 2, 2021
FacebookTwitterEmail
WASHINGTON - President Joe Biden announced Tuesday that pharmaceutical giant Merck will help make Johnson & Johnson s single-shot coronavirus vaccine - an unusual pact between fierce rivals that is among several steps intended to boost supply as Biden pushes toward having enough shots for every adult by the end of May.
Biden hailed the development as an example of industry coming together for the common good, in keeping with his frequent calls for a stronger emergency footing to combat the pandemic.